TNFα production to TLR2 ligands in active IBD patients

Clinical Immunology

Volumn 119, Issue 2, 2006, Pages 156-165

  Cantó, Elisabet ^a   Ricart, Elena ^a   Monfort, David ^a   González Juan, Dolors ^a   Balanzó, Joaquim ^a   Rodríguez Sánchez, José L ^a   Vidal, Sílvia ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Crohn's disease; TLR; TNF ; Ulcerative colitis

Indexed keywords

CD14 ANTIGEN; LIPOTEICHOIC ACID; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IRRITABLE COLON; MALE; MOLECULAR RECOGNITION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS; UPREGULATION;

ANTIGENS, CD14; CELLS, CULTURED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIGANDS; MALE; MIDDLE AGED; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645981247     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.12.005     Document Type: Article

References (42)

1. Elson C.O., Sartor R.B., Tennyson G.S., and Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 109 (1995) 1344-1367
2. Derkx B., Taminiau J., Radema S., Stronkhorst A., Wortel C., Tytgat G., and van Deventer S. Tumour-necrosis-factor antibody treatment in Crohn's disease. Lancet 342 (1993) 173-174
3. Van Deventer S.J. Tumour necrosis factor and Crohn's disease. Gut 40 (1997) 443-448
4. Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., Rennick D.M., and Sartor R.B. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66 (1998) 5224-5231
5. Schultz M., Tonkonogy S.L., Sellon R.K., Veltkamp C., Godfrey V.L., Kwon J., Grenther W.B., Balish E., Horak I., and Sartor R.B. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am. J. Physiol. 276 (1999) G1461-G1472
6. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev., Immunol. 4 (2004) 499-511
7. Cario E., and Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68 (2000) 7010-7017
8. Hausmann M., Kiessling S., Mestermann S., Webb G., Spottl T., Andus T., Scholmerich J., Herfarth H., Ray K., Falk W., and Rogler G. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122 (2002) 1987-2000
9. Probert C.S., Chott A., Turner J.R., Saubermann L.J., Stevens A.C., Bodinaku K., Elson C.O., Balk S.P., and Blumberg R.S. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. J. Immunol. 157 (1996) 3183-3191
10. Strober W., Ludviksson B.R., and Fuss I.J. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann. Intern. Med. 128 (1998) 848-856
11. Naser S.A., Ghobrial G., Romero C., and Valentine J.F. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364 (2004) 1039-1044
12. Riordan S.M., Skinner N., Nagree A., McCallum H., McIver C.J., Kurtovic J., Hamilton J.A., Bengmark S., Williams R., and Visvanathan K. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 37 (2003) 1154-1164
13. Seibl R., Birchler T., Loeliger S., Hossle J.P., Gay R.E., Saurenmann T., Michel B.A., Seger R.A., Gay S., and Lauener R.P. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am. J. Pathol. 162 (2003) 1221-1227
14. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 170 (1989) 2-6 (discussion 16-19)
15. Best W.R., Becktel J.M., Singleton J.W., and Kern Jr. F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70 (1976) 439-444
16. Truelove S.C., and Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br. Med. (1955) 1041-1048
17. Hirschfeld M., Ma Y., Weis J.H., Vogel S.N., and Weis J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165 (2000) 618-622
18. Smyth G.P., Stapleton P.P., Freeman T.A., Concannon E.M., Mestre J.R., Duff M., Maddali S., and Daly J.M. Glucocorticoid pretreatment induces cytokine overexpression and nuclear factor-kappaB activation in macrophages. J. Surg. Res. 116 (2004) 253-261
19. Gogos C.A., Skoutelis A., Lekkou A., Drosou E., Starakis I., Marangos M.N., and Bassaris H.P. Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by Gram-negative bacteria. Antimicrob. Agents Chemother. 48 (2004) 2793-2798
20. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003) 1107-1117
21. Flo T.H., Halaas O., Torp S., Ryan L., Lien E., Dybdahl B., Sundan A., and Espevik T. Differential expression of Toll-like receptor 2 in human cells. J. Leukocyte Biol. 69 (2001) 474-481
22. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168 (2002) 554-561
23. Mita Y., Dobashi K., Shimizu Y., Nakazawa T., and Mori M. Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor. Immunol. Lett. 78 (2001) 97-101
24. Komatsu M., Kobayashi D., Saito K., Furuya D., Yagihashi A., Araake H., Tsuji N., Sakamaki S., Niitsu Y., and Watanabe N. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin. Chem. 47 (2001) 1297-1301
25. Saito K., Kobayashi D., Sasaki M., Araake H., Kida T., Yagihashi A., Yajima T., Kameshima H., and Watanabe N. Detection of human serum tumor necrosis factor-alpha in healthy donors, using a highly sensitive immuno-PCR assay. Clin. Chem. 45 (1999) 665-669
26. Chen W., Paulus B., Shu D., Wilson I., and Chadwick V. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 36 (2001) 515-520
27. Ohkawara T., Nishihira J., Takeda H., Hige S., Kato M., Sugiyama T., Iwanaga T., Nakamura H., Mizue Y., and Asaka M. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 123 (2002) 256-270
28. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., Espevik T., and Ziegler-Heitbrock L. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168 (2002) 3536-3542
29. de Baey A., Mende I., Baretton G., Greiner A., Hartl W.H., Baeuerle P.A., and Diepolder H.M. A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha. J. Immunol. 170 (2003) 5089-5094
30. Naik S., Kelly E.J., Meijer L., Pettersson S., and Sanderson I.R. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J. Pediatr. Gastroenterol. Nutr. 32 (2001) 449-453
31. Abreu M.T., Vora P., Faure E., Thomas L.S., Arnold E.T., and Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167 (2001) 1609-1616
32. Melmed G., Thomas L.S., Lee N., Tesfay S.Y., Lukasek K., Michelsen K.S., Zhou Y., Hu B., Arditi M., and Abreu M.T. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170 (2003) 1406-1415
33. Ellingsen E., Morath S., Flo T., Schromm A., Hartung T., Thiemermann C., Espevik T., Golenbock D., Foster D., Solberg R., Aasen A., and Wang J. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med. Sci. Monit. 8 (2002) BR149-BR156
34. LeBouder E., Rey-Nores J.E., Rushmere N.K., Grigorov M., Lawn S.D., Affolter M., Griffin G.E., Ferrara P., Schiffrin E.J., Morgan B.P., and Labeta M.O. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171 (2003) 6680-6689
35. Jacinto R., Hartung T., McCall C., and Li L. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J. Immunol. 168 (2002) 6136-6141
36. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
37. Grimm M.C., Pullman W.E., Bennett G.M., Sullivan P.J., Pavli P., and Doe W.F. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J. Gastroenterol. Hepatol. 10 (1995) 387-395
38. Matsuguchi T., Musikacharoen T., Ogawa T., and Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J. Immunol. 165 (2000) 5767-5772
39. Lodes M.J., Cong Y., Elson C.O., Mohamath R., Landers C.J., Targan S.R., Fort M., and Hershberg R.M. Bacterial flagellin is a dominant antigen in Crohn disease. J. Clin. Invest. 113 (2004) 1296-1306
40. Weiss D.S., Raupach B., Takeda K., Akira S., and Zychlinsky A. Toll-like receptors are temporally involved in host defense. J. Immunol. 172 (2004) 4463-4469
41. Hearing S.D., Norman M., Probert C.S., Haslam N., and Dayan C.M. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45 (1999) 382-388
42. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., and Schwartz D.A. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68 (2000) 6398-6401